Brief: Coya Therapeutics Appoints Industry And Drug Development Veteran Dr Fred Grossman To President And Chief Medical Officer Succeeding Dr Adrian Hepner
05/07/2023 13:42
July 5 (Reuters) - Coya Therapeutics Inc COYA.O :
* COYA THERAPEUTICS (“COYA”) APPOINTS INDUSTRY AND DRUG
DEVELOPMENT VETERAN, DR. FRED GROSSMAN, TO PRESIDENT AND CHIEF
MEDICAL OFFICER SUCCEEDING DR. ADRIAN HEPNER
Source text for Eikon: ID:nBw16Ppqfa
Further company coverage: COYA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)